Clinical trials of a new tuberculosis (TB) vaccine recently kicked off in Kenya, meanwhile international TB researchers and activists are worried by funding gaps that may worsen in the global financial crisis.
In the first stage of human testing, known as Phase I trials, the new vaccine will be tested for safety on healthy adults with no previous history of TB in Kombewa, near Kisumu in western Kenya.
